APP and Alzheimer disease: Neuroblastoma differentiation marker 29 (NDM29), which is an RNA polymerase (pol) III-transcribed ncRNA, can be promoted by inflammatory stimuli and induces APP synthesis, leading to the increase of Aβ secretion and the process may occur in AD (Figure 1).34